Kymera Therapeutics Inc.
KYMR | NASDAQ
$117.67
-$0.08 (-0.07%)
At close: Sep 21, 2026, 4:00 PM ET
$117.67
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 39.2M | 47.07M | 78.59M | 46.83M | 72.83M | 34.03M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 39.2M | 47.07M | 78.59M | 46.83M | 72.83M | 34.03M |
Operating Income | -349.4M | -261.64M | -165.53M | -161.26M | -100.53M | -46.3M |
Interest Income | 38.03M | 38.03M | 18.76M | 6.62M | 488K | 826K |
Pretax Income | -311.62M | -223.86M | -146.96M | -154.81M | -100.22M | -45.59M |
Net Income | -311.4M | -223.86M | -146.96M | -154.81M | -100.22M | -45.59M |
Selling & General & Admin | 68.2M | 63.53M | 55.04M | 43.83M | 36.35M | 18.23M |
Research & Development | 316.6M | 240.25M | 189.08M | 164.25M | 137.02M | 62.11M |
Other Expenses | 3.8M | 4.93M | n/a | n/a | n/a | n/a |
Operating Expenses | 388.6M | 308.71M | 244.12M | 208.08M | 173.36M | 80.34M |
Interest Expense | 249K | 249K | 196K | 176K | 175K | 115K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 388.6M | 308.71M | 244.12M | 208.08M | 173.36M | 80.34M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 84.39M | 75.04M | 58.37M | 53.93M | 47.99M | 44.56M |
Shares Outstanding (Diluted) | 84.39M | 75.04M | 58.37M | 53.93M | 47.99M | 44.56M |
EPS (Basic) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 |
EPS (Diluted) | -3.69 | -2.98 | -2.52 | -2.87 | -2.09 | -0.99 |
EBITDA | -303.06M | -216.24M | -143.2M | -151.66M | -97.65M | -43.72M |
EBIT | -311.37M | -223.61M | -146.77M | -154.63M | -100.04M | -45.48M |
Depreciation & Amortization | 8.31M | 7.37M | 3.57M | 2.98M | 2.4M | 1.76M |
Add to Watchlist
Select watchlists to add or remove KYMR